[Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders].
The effect of phenazepam therapy in a dose of 2 mg daily on short-term memory function was studied in 58 patients with borderline neuropsychic disorders. Concomitant differential assessment of the changes observed in psychoemotional tension and psychopathological symptomatology over time was also carried out by using both clinical findings and results of psychological tests. The discrepancy found between the patients' complaints of memory deterioration following tranquilizer therapy and the absence of any signs of such an impairment as judged by the data obtained by special tests is explained by lowered levels of emotional and motivational tension. This hypothesis is substantiated by both clinical evidence and psychological data.
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents; D001007:Anxiety / Q000188:drug therapy; D001247:Asthenia / Q000188:drug therapy; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000009:adverse effects*; D001883:Borderline Personality Disorder / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy; D004644:Emotions; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced; D008570:Memory, Short-Term; D008875:Middle Aged; D009042:Motivation; D010554:Personality Disorders / Q000188:drug therapy*; D013577:Syndrome
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; C017928:phenazepam
Vliianie trankvilizatorov na kratkovremennuiu pamiat' u bol'nykh s pogranichnymi formami nervno-psikhicheskikh rasstroĭstv.